Jefferson researchers find uterine artery embolization may negatively affect future pregnancies

October 31, 2002

A study in the November issue of Obstetrics & Gynecology by physicians at Thomas Jefferson University Hospital in Philadelphia found that women who undergo uterine artery embolization (UAE)--a relatively new procedure that is increasingly used as an alternative to myomectomy and hysterectomy to treat uterine fibroids--are at an increased risk for a number of complications if they later become pregnant.

Fibroids are benign tumors of smooth muscle that grow in the uterus and occur in up to one quarter of women of childbearing age. Fibroids can cause abnormal bleeding, pelvic pain and infertility. Uterine artery embolization is often effective. It is a minimally invasive radiologic procedure that blocks the arteries that supply blood to fibroid tumors, which results in shrinking the tumors by up to 40 percent.

An analysis of 50 published cases of pregnancy after uterine artery embolization by physicians in the Department of Obstetrics and Gynecology at Jefferson Medical College of Thomas Jefferson University in Philadelphia found that pregnant women were at a significantly higher risk for premature delivery, miscarriage, postpartum hemorrhage, breech presentation of the baby and cesarean section.

"Although there is no definitive cause and effect, it is important to be aware of the possible relationship between these complications and prior uterine artery embolization because of the increasing number of women desiring future fertility who are electing to undergo this therapy," says lead author Jay Goldberg, M.D., clinical assistant professor of Obstetrics and Gynecology at Jefferson Medical College.

"Based on the available data, women becoming pregnant after uterine artery embolization may be at significantly increased risk for postpartum hemorrhage, preterm delivery and cesarean delivery," Dr. Goldberg adds.

The study compares complication rates in the following categories: Additional researchers at Jefferson who participated in the study are Leonardo Pereira, M.D., and Vincenzo Berghella, M.D.
Additional Contact Information:
Nan Myers or Phyllis Fisher
After Hours: 215-955-6060

Thomas Jefferson University

Related Tumors Articles from Brightsurf:

A viable vaccine for tough tumors
While immunotherapies work well for some cancers, others are immune-resistant and condemn patients to the severe side effects of long-term chemo treatment.

Women could conceive after ovarian tumors
Women receiving fertility-sparing surgery for treatment of borderline ovarian tumours were able to have children, a study from Karolinska Institutet in Sweden published in Fertility & Sterility shows.

Attacking tumors from the inside
A new technology that allows researchers to peer inside malignant tumors shows that two experimental drugs can normalize aberrant blood vessels, oxygenation, and other aspects of the tumor microenvironment in non-small cell lung cancer (NSCLC), helping to suppress the tumor's growth and spread, UT Southwestern researchers report.

Directing nanoparticles straight to tumors
Modern anticancer therapies aim to attack tumor cells while sparing healthy tissue.

A solid vaccine for liquid tumors
Acute myeloid leukemia (AML) is a deadly blood cancer that kills most of its victims within five years.

Evolutionarily novel genes work in tumors
A team of scientists from Peter the Great St. Petersburg Polytechnic University studied the evolutionary ages of human genes and identified a new class of them expressed in tumors -- tumor specifically expressed, evolutionarily novel (TSEEN) genes.

Identification of all types of germ cells tumors
Germ cell tumors were considered very heterogeneous and diverse, until recently.

Laser light detects tumors
A team of researchers from Jena presents a groundbreaking new method for the rapid, gentle and reliable detection of tumors with laser light.

Better prognosticating for dogs with mammary tumors
For dogs with mammary tumors, deciding a course of treatment can depend on a variety of factors, some of which may seem to contradict one another.

The evolution of brain tumors
Scientists from the German Cancer Research Center found in a recent study that only three different genetic alterations drive the early development of malignant glioblastomas.

Read More: Tumors News and Tumors Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to